ZVRA Latest Press Releases

-- October 20, 2026 --

Zevra Therapeutics Announces Details for Q3 2026 Financial Results Call Globe Newswire 7:30 AM

-- September 2, 2026 --

Zevra Therapeutics to Present at Upcoming Investor Conferences Globe Newswire 7:30 AM

-- August 25, 2026 --

Zevra Therapeutics to Present New Long-Term Real-World Data on MIPLYFFA in Niemann-Pick Disease Type C (NPC) at the 2026 SSIEM Annual Symposium Globe Newswire 7:30 AM

-- August 21, 2026 --

Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

-- August 6, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA PRNewswire 11:02 PM

-- August 5, 2026 --

Zevra Reports Second Quarter 2026 Financial Results and Corporate Update Globe Newswire 4:05 PM

-- August 4, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA Globe Newswire 5:40 PM

Zevra Therapeutics to Present at the Canaccord Genuity Annual Growth Conference Globe Newswire 7:30 AM

-- August 3, 2026 --

Zevra Therapeutics (ZVRA) Securities Investigation Notice - Levi & Korsinsky Globe Newswire 10:38 AM

Zevra Therapeutics (ZVRA) Securities Investigation Notice - Levi & Korsinsky PRNewswire 10:07 AM

Zevra Therapeutics Announces Publication of Four-Year Real-World Data from U.S. Early Access Program Evaluating MIPLYFFA (arimoclomol) in Niemann-Pick Disease Type C (NPC) Globe Newswire 7:30 AM

-- July 30, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA PRNewswire 10:01 AM

-- July 29, 2026 --

ZVRA Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Zevra Therapeutics (ZVRA) Business Wire 10:07 AM

-- July 28, 2026 --

ZVRA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Zevra Therapeutics PRNewswire 10:10 AM

-- July 27, 2026 --

ZVRA Investors Have Opportunity to Join Zevra Therapeutics, Inc. Fraud Investigation with SBS Law Business Wire 8:40 PM

Zevra Therapeutics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Zevra Therapeutics (ZVRA) PRNewswire 5:19 PM

-- July 24, 2026 --

Zevra Therapeutics Provides Update on Regulatory Submission for Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union Globe Newswire 7:30 AM

-- July 22, 2026 --

Zevra Therapeutics Announces Details for Q2 2026 Financial Results Call Globe Newswire 7:30 AM

-- June 23, 2026 --

Zevra Therapeutics Announces Publication of Positive MIPLYFFA Data from Pediatric Substudy in Infants with Niemann-Pick Disease Type C (NPC) Globe Newswire 7:30 AM

-- June 11, 2026 --

Zevra's Chief Medical Officer to Step Down for Personal Reasons as Part of Planned Transition Globe Newswire 8:30 AM

-- June 8, 2026 --

Zevra Therapeutics Announces Orange Book Listing of U.S. Patent Strengthening Exclusivity for MIPLYFFA Globe Newswire 7:30 AM

Market Data Delayed 15 Minutes